IL17A and chronic obstructive pulmonary disease: We identified 28% of GLUCOLD participants as having high IL-17 gene expression (“IL-17–high”) by cluster partitioning (31% of COPD participants over all 3 studies, including 33% of BAE and 34% of SPIROMICS participants, were IL-17 high; Supplemental Figure 6).